GEN Exclusives

More »

The Lists

More »
Aug 12, 2013

The 20 Top Paid Women Executives in Biopharma

Who are the highest-paid females in the industry this year?

The 20 Top Paid Women Executives in Biopharma

See how well these 20 sisters are doin’ it for themselves. [© stefa_neve - Fotolia.com]

  • #10. Jacqualyn A. Fouse, Ph.D.

    Company: Celgene

    Title: EVP and CFO

    2012 Compensation: $3,450,103

    2011 Compensation: $2,535,033

    % Change: 36.1%

  • #9. Robin L. Washington

    Company: Gilead Sciences

    Title: SVP and CFO

    2012 Compensation: $4,175,593

    2011 Compensation: $4,032,193

    % Change: 3.6%

  • #8. Sandra Peterson

    Company: Johnson & Johnson

    Title: Group Worldwide Chair

    2012 Compensation: $4,698,8506

    2011 Compensation: N/A6

    % Change: N/A6

  • #7. Silvia Ayyoubi

    Company: Roche

    Title: Head, Group Human Resources

    2012 Compensation: $5,346,932 (CHF 4,970,897)1

    2011 Compensation: $4,342,348 (CHF 4,037,074)1,7

    % Change: 23.1%

  • #6. Amy W. Schulman

    Company: Pfizer

    Title: EVP and General Counsel; Business Unit Lead, Consumer Healthcare

    2012 Compensation: $5,573,218

    2011 Compensation: $5,764,662

    % Change: -3.3%

  • #5. Sandra Leung

    Company: Bristol-Myers Squibb

    Title: General Counsel & Corporate Secretary

    2012 Compensation: $5,892,772

    2011 Compensation: $5,491,673

    % Change: 7.3%

  • #4. Martine Rothblatt

    Company: United Therapeutics

    Title: CEO

    2012 Compensation: $7,958,328

    2011 Compensation: $3,161,350

    % Change: 151.7%

  • #3. Heather Bresch

    Company: Mylan

    Title: CEO

    2012 Compensation: $8,000,628

    2011 Compensation: $9,208,0348

    % Change: -13.1%

  • #2. Beatrice Cazala

    Company: Bristol-Myers Squibb

    Title: EVP, Commercial Operations

    2012 Compensation: $8,031,025

    2011 Compensation: $5,941,1679

    % Change: 35.2%

  • #1. Laura J. Schumacher

    Company: AbbVie

    Title: EVP, Business Development, External Affairs and General Counsel

    2012 Compensation: $10,192,74810

    2011 Compensation: $5,567,49310

    % Change: 83.1%


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?